Health Risks and Limited Benefits of Nicotine

Adverse Health Effects

• Nicotine is a highly addictive substance that affects many body cells, mediators, and metabolic pathways, according to the American Thoracic Society 1, 2
• Nicotine is associated with significant cardiovascular effects that may contribute to coronary artery disease, atherosclerosis, and aortic aneurysms, as reported by the American Thoracic Society 1, 3
• Nicotine is linked to the development of peptic ulcer and gastrointestinal cancer, as noted by the American Thoracic Society 3
• Nicotine may promote tumor angiogenesis, according to the American Thoracic Society 3
• Nicotine causes neurotoxic effects on the developing brain, particularly concerning in adolescents, as stated by the American Academy of Pediatrics 4
• Nicotine functions as a potential "gateway" drug for cocaine and other illicit drugs in adolescents, as reported by the American Academy of Pediatrics 4
• Nicotine adversely affects children during prenatal development through adolescence, according to the American Thoracic Society 3
• In utero exposure to nicotine is linked to impaired fertility, type 2 diabetes, obesity, hypertension, neurobehavioral defects, and respiratory dysfunction, as noted by the American Thoracic Society 3
• Nicotine affects neuroregulation and structural changes in the brain and lung that could increase vulnerability to hypoxia, according to the American Thoracic Society 3
• Nicotine has deleterious effects on bone health in both animal models and humans, as reported by the American Thoracic Society 3
• Nicotine has genotoxic effects on fetal cells, according to the American Thoracic Society 3

Limited Potential Benefits

• Nicotine appears to exert anti-inflammatory effects by stimulating the cholinergic anti-inflammatory response, suppressing nuclear factor-κB-dependent transcriptional events, inhibiting the release of proinflammatory cytokines from macrophages, and decreasing leukocyte infiltration and proinflammatory cytokine concentrations in models of acute lung injury, as noted by the European Respiratory Society 5
• Medicinal nicotine as an aid to smoking cessation has a good safety record when properly regulated, according to the American Thoracic Society 3
• Standardized doses and release mechanisms in approved nicotine replacement therapies have been extensively tested, as reported by the American Thoracic Society 3

Important Caveats and Limitations

• The potential anti-inflammatory effects observed in animal models lack sufficient epidemiological or experimental evidence in humans, as noted by the European Respiratory Society 5
• Any potential benefits of nicotine are significantly outweighed by its harmful effects, particularly its high addiction potential, according to the European Respiratory Society 5
• Recreational use of nicotine products should be strongly discouraged due to adverse cardiopulmonary effects and addiction risk, as stated by the European Respiratory Society 5
• Electronic cigarettes and other non-regulated nicotine delivery systems have not been adequately tested, standardized, or regulated, making their safety uncertain, according to the American Thoracic Society 3

Special Populations at Risk

• Pregnant women: Nicotine exposure during pregnancy can lead to numerous adverse developmental outcomes, as reported by the American Thoracic Society and the American Academy of Pediatrics 3, 4
• Adolescents: Particularly vulnerable to nicotine addiction and neurodevelopmental effects, according to the American Academy of Pediatrics and the American Thoracic Society 4, 6
• Children: At risk from secondhand and thirdhand exposure, as noted by the American Academy of Pediatrics 4, 7
• Non-users: Exposed to harmful toxicants through secondhand and thirdhand aerosol from electronic nicotine delivery systems, according to the American Academy of Pediatrics 7

Clinical Implications

• Any therapeutic application of nicotine should only be considered in regulated medical contexts with standardized dosing, as recommended by the American Thoracic Society 3
• The potential cognitive benefits of nicotine should not be used to justify recreational nicotine use, according to the European Respiratory Society 5